Interventional bleeding, hematoma and scar-formation after vacuum-biopsy under stereotactic guidance: Mammotome(®)-system 11 g/8 g vs. ATEC(®)-system 12 g/9 g
- PMID: 22381441
- DOI: 10.1016/j.ejrad.2012.01.033
Interventional bleeding, hematoma and scar-formation after vacuum-biopsy under stereotactic guidance: Mammotome(®)-system 11 g/8 g vs. ATEC(®)-system 12 g/9 g
Abstract
Purpose: To evaluate prospectively the correlation of scar-formations after vacuum-assisted biopsy with different systems and needle-sizes and interventional bleeding/post-interventional hematoma.
Methods and materials: Between 01/2008 and 12/2009, 479 patients underwent vacuum-assisted biopsy under stereotactic-guidance, using the Mammotome(®)-system with 11/8-gauge and ATEC(®)-system with 12/9-gauge, whereas in 178 cases with representative benign histology no surgical-biopsy after vacuum-assisted biopsy was performed and at least a 2-plane-follow-up-mammogram after 6 month post-vacuum-assisted biopsy was available. Bleeding during intervention, hematoma post-intervention and scar-tissue was scored as minimal and moderate/severe. Statistical analysis included Chi-Square-trend-test, p-value <0.05 was considered to be significant.
Results: Significantly more bleedings and post-interventional hematomas for 8-gauge-Mammotome(®)-system vs. 11-gauge-Mammotome(®)-system (41.9% vs. 8.4%, p<0.001/35.5% vs. 16.7%, p=0.029), no significant-differences for the ATEC(®)-systems 9-gauge vs. 12-gauge (26.9% vs. 29.7%, p=0.799/42.3% vs. 43.2%, p=0.596). 11-gauge-Mammotome(®)-system vs. ATEC(®)-12-gauge-system revealed significantly less bleedings/hematomas (8.4% vs. 29.7%, p=0.015/16.7% vs. 43.2%, p=0.001), no significant differences for the large-systems (p=0.135/p=0.352). Follow-up of Mammotome(®)-11/8-gauge-system system has shown 13.1/16.1% minimal scar-formation and 1.2/3.2% moderate/severe scars, whereas ATEC(®)-12/9-gauge-system has shown 10.8/3.8% minimal scar-formation and 0/11.5% moderate/severe scars, no significant differences. No significant difference was found when comparing Mammotome(®)-11/8-g-systems vs. ATEC(®)-12/9-g-systems (p=0.609/p=0.823). There was also no correlation between risk of scar-formation after occurrence of bleeding or hematoma with any examined VAB-system or any needle size in this study (p=0.800).
Conclusion: Using larger needle-sizes significantly (Mammotome(®))/not significant for ATEC(®)) more interventional bleedings and post-interventional hematomas were detected, only a tendency concerning scar-formation.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Evaluation of two different vacuum-assisted breast biopsy systems: Mammotome(R) system 11G/8G vs. ATEC(R) system 12G/9G.Acta Radiol. 2013 Mar 1;54(2):137-43. doi: 10.1258/ar.2012.120420. Epub 2013 Jan 14. Acta Radiol. 2013. PMID: 23319718
-
Percutaneous excisional biopsy of clinically benign breast lesions with vacuum-assisted system: comparison of three devices.Eur J Radiol. 2012 Apr;81(4):725-30. doi: 10.1016/j.ejrad.2011.01.059. Epub 2011 Feb 5. Eur J Radiol. 2012. PMID: 21300503
-
Stereotactic core biopsy: Comparison of 11 gauge with 8 gauge vacuum assisted breast biopsy.Eur J Radiol. 2012 Oct;81(10):2613-9. doi: 10.1016/j.ejrad.2011.10.027. Epub 2011 Nov 27. Eur J Radiol. 2012. PMID: 22127375
-
Differentiating vacuum-assisted breast biopsy from core needle biopsy: Is it necessary?Br J Radiol. 2018 Dec;91(1092):20180250. doi: 10.1259/bjr.20180250. Epub 2018 Jul 20. Br J Radiol. 2018. PMID: 29975150 Free PMC article. Review.
-
An analysis of the respective risks of hematoma formation in 361 consecutive morphological and functional stereotactic procedures.Neurosurgery. 2002 Jan;50(1):48-56; discussion 56-7. doi: 10.1097/00006123-200201000-00010. Neurosurgery. 2002. PMID: 11844234 Review.
Cited by
-
The Efficacy of Thrombin-Gelatin Matrix in Hemostasis for Large Breast Tumor after Vacuum-Assisted Breast Biopsy.J Pers Med. 2022 Feb 17;12(2):301. doi: 10.3390/jpm12020301. J Pers Med. 2022. PMID: 35207791 Free PMC article.
-
Hemorrhagic Complications Following Ultrasound-Guided Breast Biopsy: A Prospective Patient-Centered Study.Korean J Radiol. 2024 Feb;25(2):157-165. doi: 10.3348/kjr.2023.0874. Korean J Radiol. 2024. PMID: 38288896 Free PMC article.
-
Feasibility and safety of image-guided vacuum-assisted breast biopsy: A PRISMA-compliant systematic review and meta-analysis of 20 000 population from 36 longitudinal studies.Int Wound J. 2019 Dec;16(6):1506-1512. doi: 10.1111/iwj.13224. Epub 2019 Sep 18. Int Wound J. 2019. PMID: 31531950 Free PMC article.
-
Unusual Presentation of a Post-procedural Breast Hematoma: A Case Report.In Vivo. 2021 Sep-Oct;35(5):2957-2961. doi: 10.21873/invivo.12589. In Vivo. 2021. PMID: 34410994 Free PMC article.
-
Randomized controlled trial of stereotactic 11-G vacuum-assisted core biopsy for the diagnosis and management of mammographic microcalcification.Br J Radiol. 2016;89(1058):20150504. doi: 10.1259/bjr.20150504. Epub 2015 Dec 14. Br J Radiol. 2016. PMID: 26654214 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical